Eric Weiss, MD, uses Stemell® umbilical cord tissue and cord blood stem cells for treatment of certain medical conditions at North Florida Stem Cells in Orange Park and Jacksonville, FL
Dr. Weiss chose Stemell®, a leading biotech company focused on obtaining and isolating stem cells to manufacture innovative cord blood tissue and cord blood products, as North Florida Stem Cells’ primary resource. Stemell’s proprietary technology is changing the tradition that unwanted umbilical cord should be wasted; rather, cord blood and tissue should be utilized as products for healing medical therapies and treatments.
What are these cells?
Umbilical cord stem cells are living cells that are “transplanted” into the patient. It’s imperative to understand that the most beneficial the cells must be alive. The industry standard for living cells at the time of infusion (transplantation) is between 40-60%. With Stemell’s proprietary technology, viability is over 90% – another reason Dr. Weiss chose Stemell. It’s important to know that Stemell has developed the industry’s golden standard of best practices for the viability of cells we use in our therapies and treatments. Their FDA-approved products are fresh and delivered directly to the lab right before the procedure.
Stemell is creating and developing new paths to therapy and making these cells available to physicians to manage pain and in certain cases heal medical conditions successfully. Dr. Weiss carefully reviewed and researched multiple labs that provide umbilical cord blood stem cells. He chooses Stemell because of:
- FDA registration and recognition of Stemell’s “good tissue practice”
- Quality control
- Quality assurance
- Donor eligibility
- Licensed as a tissue bank (CA)
Viability of stem cells counts for these procedures. Dr. Weiss believes Stemell leads the industry, continues to surpass all FDA standards covering stem cells, and sets the “gold standard” of providing the safest and most viable cells of any lab. Viewing the umbilical cord blood and tissue as the preeminent source of stem cells and biological components, Stemell intends to create a new hybrid biobank in the future. Their contribution to the future of cellular-based therapies benefits humankind.
Knowing what stem cells can do for you is an important first step
Our responsibility is to education each patient so there is a clear understanding of the stem cell therapy process using Stemell.
What are the eligibility criteria for a donor?
- A donor is eligible to donate tissue for transplantation based on eligibility criteria:
- A prescreen review of medical history through the medical record
- Evaluation of prenatal tests
- Physical assessment
- Behavior risk assessment
- Review of blood test results
- Communicable disease test results
- Blood sample test results along with information from other records or sources pertaining to donor suitability and evaluation by a Medical Director
Discussions with physicians and/or the donor mother are conducted to identify conditions that may result in the exclusion of the donor or donated tissue. This information is used to determine that the donor suitability criteria at the time of tissue recovery have been met, and the tissue is acceptable for transplantation.
How does Stemell collect fresh cells?
Human cord blood is collected by sterile technique from a pre-screened from a healthy pregnant donor at the time of delivery for:
- Syphilis, antibody screen, and ABO RH
- Infectious disease panel of testing
Including for Hepatitis B Core Antibody, Hepatitis C Surface Antigen, Hepatitis C Virus Antibody, HIV Antibody, Hunan T-Lymphotropic Virus Antibody, HIV-1/HCV/HBV Nucleic Acid Testing, WNV Nucleic Acid Testing, Chagas Disease Antibody, Lyme Disease abs/Total EIISA with Reflex to Western Blot, and Cytomegalovirus ABS
The donor’s cells are collected at the time of delivery in a CPD anticoagulant in a sterile collection bag. Human cord blood stem cells are harvested in a certified, class-100 cleanroom under best practices. For quality control each lot of umbilical cord blood stem cells is tested for growth and viability and then stored in freezing media, analyzed via hematology analyzer, and counted with cell counter.